Delivery Order SPE2DB22D1106-SPE2DB25FEYT8
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,288.98 to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Nora-Be Tablet 28S, a pharmaceutical product. This firm fixed-price delivery order, which is expected to be completed by July 21, 2025, was competitively awarded with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, reflecting the company's role as a primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,467.22 Firm Fixed Price delivery order is for the supply of NORA-BE TABLET 28S, a pharmaceutical product. The contract has a period of performance through November 10, 2022. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,439.20 Firm Fixed Price Delivery Order contract is for the provision of NORA-BE TABLET 28S, a pharmaceutical product. The contract has an ultimate completion date of April 1, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,936.52 firm fixed-price delivery order is for the supply of NORA-BE TABLET 28S medical products, with a period of performance through November 15, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a $569 firm fixed price delivery order contract to Amerisourcebergen Drug Corporation to supply 4561731751 NORA-BE TABLETS 28S. As the prime contractor, Amerisourcebergen will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by August 8, 2023 under the terms of the order. The Defense Logistics Agency functions to support military readiness by procuring and providing logistics support for the Department of Defense, indicating the...
- This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is a Delivery Order valued at $2,878.44 with a Firm Fixed Price pricing type. It is for the provision of "NORA-BE TABLET 28S", a pharmaceutical product. The contract has a period of performance that runs through June 13, 2024. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, holds a significant...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on June 25, 2025, for the supply of Norethindrone 5 mg tablets (90-count units). This firm fixed-price delivery order, valued at $2,643.64, represents a non-competitive set-aside award and is scheduled for completion by June 26, 2025. The place of performance is located at AmerisourceBergen's corporate office in Conshohocken,...
- The Defense Logistics Agency awarded a $3,237.04 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Norgestimate-EE 0.25-0.035 mg 28-tablet pack pharmaceutical supplies. The contract was awarded on August 8, 2025, with an ultimate completion date of August 11, 2025, and will be performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents a non-competitive award issued under a larger indefinite delivery contract vehicle. This...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for ORSERDU 345 mg tablets in a 30-count package. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $27,841.82 with an ultimate completion date of August 11, 2025. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Orserdu 345 mg tablets (30-count packages) with a ceiling value of $27,841.82. This firm fixed-price delivery order, which is scheduled for completion by October 6, 2025, carries no set-aside designation and represents a competitively awarded contract. The order will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania facility, where the company maintains its...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FEYT8Delivery Order
The Defense Logistics Agency awarded a $3,365.16 delivery order to AmerisourceBergen Drug Corp on July 19, 2025, for the supply of Nora-Be Tablet 28S pharmaceutical product. This is a firm fixed price, competitively awarded delivery order with an ultimate completion date of July 21, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating full and open competition among qualified vendors. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a prime vendor under this comprehensive global pharmaceutical support vehicle, AmerisourceBergen supplies a broad range of medications and medical commodities to support military healthcare programs and other federal health systems. The company's role as a critical pharmaceutical distributor for the federal government is evidenced by its extensive portfolio of competitively awarded contracts with DLA, which collectively demonstrate capability to fulfill diverse medical supply requirements across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.4k | 7/19/25 |